SUZANN SMITH: Open Payments
NPI 1811220171 · MANCHESTER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 35 payments from 12 companies in 2025. Trend: 2023 $1,050 · 2024 $847 · 2025 $682
Food & beverage: $682
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $104 |
| Otsuka America Pharmaceutical, Inc. | 5 | $86 |
| Lundbeck LLC | 4 | $77 |
| Alkermes, Inc. | 4 | $71 |
| Janssen Pharmaceuticals, Inc | 3 | $69 |
| Vanda Pharmaceuticals Inc. | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
| Indivior Inc. | 2 | $39 |
| Biogen, Inc. | 1 | $25 |
Products named: ABILIFY ASIMTUFII, VRAYLAR, ARISTADA, SPRAVATO, HETLIOZ, UZEDY, REXULTI, CAPLYTA.
Industry payments across KY — which companies pay providers there.
